🔎 Trials Near Me

Home › Knee Osteoarthritis › NCT07580222

Mobile Technology to Measure Knee Health in Osteoarthritis

RecruitingObservational study

Using Mobile Technology to Extract Mechanical Markers of Joint Health and Function in Early Knee Osteoarthritis

Who can join

Ages 30 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Veteran and non-Veterans
* males and females
* diagnosed with early knee osteoarthritis
* qualified for and participated in the Precision Assessment of Platelet Rich Plasma for Joint Preservation study (ClinicalTrials.gov ID: NCT03460236)
* able and willing to provide informed consent for follow-up study

Exclusion Criteria:

* symptomatic OA in joints other than the knee in the lower body
* joint replacement
* rheumatic disease
* BMI \> 35 kg/m\^2
* severe systematic disease defined as American Society of Anesthesiologists (ASA) 3 or above
* pregnant or intending to become pregnant during the study

About the study

Veterans face a high prevalence of knee osteoarthritis (OA), but current diagnostic methods often miss early stages when interventions are more effective. This project will evaluate smartphone-based motion capture via OpenCap to measure joint mechanics in knee OA patients during functional activities, comparing its performance to a conventional motion capture system, patient-reported symptoms, and knee joint structure. The findings will have the potential to enable clinicians to trial OpenCap in its current form, provide insights into tracking joint health, and guide refinements to advance toward earlier diagnosis of knee OA by complementing symptom assessments with measures of joint mechanics.

Sponsor: VA Office of Research and Development · Participants: 47 · Started: Apr 1, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07580222

Locations in the U.S.

CaliforniaVA Palo Alto Health Care System, Palo Alto, CA, Palo Alto

Conditions

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.